Indian Journal of Hygiene & Public Health

Guidelines for Contributors

SUBMISSION OF MANUSCRIPT

Only articles which have not been published and are not under consideration for publication in any other journal may be submitted to this Journal. All manuscripts will become the property of the Indian Journal of Hygiene & Public Health. The soft copy of the article is to be submitted at email – aiihphjournal@gmail.com addressed to the Chief Editor.

The manuscript should be submitted in the form of two separate files in MS Word font "Times New Roman" with font size - Title -18 , Subtitle -14 and Text -12 (including Tables, References and Abstract ).

The submitted manuscripts that are not as per the “Guidelines for contributors” would be returned to the authors for technical correction, before they undergo editorial/ peer-review.

Generally, the manuscript should be submitted in the form of two separate files.

  1. Title Page/First Page File:

  2. This file should provide :

    1. The type of manuscript (original article, case report, review article, Letter to editor, etc.), title of the manuscript, running title, names of all authors/ contributors (with their designation and affiliations) and name(s) of department(s) and/ or institution(s) to which the work should be credited . All information which can reveal identity of authors should be here.

    2. The total number of photographs and word counts separately for abstract and for the text (excluding the references, tables and abstract)

    3. Source(s) of support in the form of grants, equipment, drugs, or all of these

    4. The name, address, e-mail, and telephone number of the corresponding author, who is responsible for communicating with other authors about editorial decisions like revisions and final approval of the proofs.

    5. The JOURNAL will not publish any paper unless we get the signatures of all authors

  3. Article file:
  4. This file must not contain any mention of the authors' names or initials or the institution at which the study was done. The main text of the article, beginning from Title till References (including tables) should be in this file.
    The manuscripts submitted for publication to the IJHPH should include the following:

    1. COVERING LETTER
    2. The covering letter should identify one of the authors as the corresponding author of the paper, who would be accountable for the contents of the paper as also respond to any queries pertaining to the paper. The covering letter should mention word count of the abstract and main text, number of references, figures and table

    3. MANUSCRIPT
    4. Manuscripts must be submitted by email to aiihphjournal@gmail.com.

      The Journal uses American spellings. Word limits should be adhered to. Editorial/viewpoint should be about 1500 words, and continuing medical education/review articles should be limited to 4500 words. Original articles should limit to 3000 and short articles to 1500 words, letters and book review should be limited to 750 and 500 words respectively. This word limit includes abstract, references and tables etc. Word count should be mentioned on the main article file. Authors are advised to consult Uniform Requirements for Manuscripts (URM) submitted to Biomedical Journals before submission of manuscript ( http://www.icmje.org ). The articles should mention how human and animal ethical aspect was addressed and whether informed consent was taken if applicable. Identifying details need not be given if they are not essential. For experiment on human subjects, it should be indicated whether the procedures followed were in accordance with the Helsinki Declaration of 1975, as revised in 2000. (http://www.wma.net).

      Each of the following sections should begin on a separate page. All pages should be numbered in sequence beginning with the title page.

  5. Original articles:
  6. There should be generally not more than six authors for these articles.

    Population based surveys, program evaluations, impact assessment studies, randomized controlled trials, intervention studies, studies of screening and diagnostic test, outcome studies, cost effectiveness analyses, meta-analysis, systematic reviews, cohort studies and case-control studies may be considered original articles. The word limit for original articles is 3000 words (excluding Abstract, references and Tables) and the text should be divided into sections with the headings Abstract, Key-words, Introduction, Material and Methods, Results, Discussion, References, Tables and Figure legends.

    Manuscripts typewritten neatly in double space should be presented in concise form,. Pages should be numbered consecutively and the contents arranged in the following order:

    1. Title
    2. Title of the article should be short, continuous (not broken or hyphenated) and sufficiently descriptive and informative to be useful in indexing and information retrieval.

      Title page should include Name(s) of author(s) with departmental affiliations, complete postal addresses with e-mails should be given in the Title page.

      A short running title not exceeding 6-7 words may also be provided.


    3. Abstract
    4. The manuscripts should (except reviews and CMEs) have a structured abstract with subheadings of Background & objectives, Methods, Results, and Interpretation & conclusions. A structured condensation of the work should be given not exceeding 250 words for original research articles and 150 words for short articles. Abstract should be brief and the scope and significant results of the paper should be indicated. Only principal findings and conclusions should be highlighted for its use by abstracting services without modification. Abstract should not include Conclusions and recommendations not found in the text of the articles. A set of suitable key words (6-8 in number may be provided.

      Terms from the Medical Subject Headings (MESH) list of Index Medicus should preferably be used.

    5. Introduction
    6. Introduction should be brief and the scope of the paper should be clearly stated. Review of the literature should be restricted to reasons for undertaking the present study and only the most essential background may be given. The purpose and rationale for the study or observation should be specified.

    7. Material & Methods
    8. It should include and describe the following aspects:
      Ethics: A statement on ethics committee permission and ethical practices must be. In studies on human beings, it should be indicated whether the procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional or regional) and with the Helsinki Declaration of 1975, as revised in 2000 (available at http://www.wma.net/e/policy/17-c_e.html ). For prospective studies involving human participants, mention should be made about approval of (regional/ national/ institutional or independent) Ethics Committee or Review Board, obtaining informed consent from adult research participants and obtaining assent for children aged over 7 years participating in the trial. The age beyond which assent would be required could vary as per regional and/ or national guidelines. Confidentiality of subjects should be maintained . When reporting experiments on animals, it should be indicated if the institution's or a national research council's guide for, or any national law on the care and use of laboratory animals was followed. Evidence for approval by a local Ethics Committee (for both human as well as animal studies) must be supplied by the authors on demand. The ethical standards of experiments must be in accordance with the guidelines provided by the Committee for the Purpose of Control and Supervision of Experiments on Animals (CPCSEA) and World Medical Association Declaration of Helsinki on Ethical Principles for Medical Research Involving Humans for studies involving experimental animals and human beings, respectively).

    9. Study design:
    10. Selection and Description of ParticipantsThe selection of the observational or experimental participants (healthy people, patients or laboratory animals, including controls) should be described clearly, including eligibility and exclusion criteria and a description of the source population.

      Technical information: The methods, apparatus, and procedures should be given in sufficient detail to allow other workers to reproduce the results. References should be given in respect of established methods, including statistical methods (see below); new or substantially modified methods should be described with reasons for using themAll drugs and chemicals used should be precisely identified, including generic name(s), dose(s), and route(s) of administration.

      Reports of randomized clinical trials should present information on all major study elements, including the protocol, assignment of interventions (methods of randomization, concealment of allocation to treatment groups), and the method of masking (blinding), based on the CONSORT Statement ( http://www.consort-statement.org ).

    11. Statistics:
    12. The findings should be quantified and presented with appropriate indicators of measurement error or uncertainty (such as confidence intervals). Losses to observation (such as, dropouts from a clinical trial) should be reported. Statistical methods used to analyze data should be specified. Non-technical uses of technical terms such as 'random' (which implies a randomizing device), 'normal', 'significant', 'correlations', and 'sample' should be avoided. Statistical terms, abbreviations, and most symbols should be defined. Computer software used should be specified. For all P values the exact value is preferable (and not less than 0.05 or 0.001). Mean differences in continuous variables, proportions in categorical variables and relative risks including odds ratios and hazard ratios should be accompanied by their confidence intervals.

    13. Results
    14. Only essential data for understanding the discussion and main conclusions emerging from the study should be included. The results should be presented in a logical sequence in the text, tables, and illustrations, giving the main or most important findings first. The data should be arranged in clear, logical and coherent sequence. Data presented in Tables and Figures should not be repeated in the text. Only important observations need to be emphasized or summarized. The same data should not be presented both in tabular and graphic forms. Interpretation of the data should be taken up only under the Discussion and not under Results.

      Numeric results should be given not only as derivatives (for example, percentages) but also as the absolute numbers from which the derivatives were calculated, and the statistical methods used for analysis should be given. The number of figures and tables should be restricted below six. Graphs may be given as an alternative to tables with many entries. Data in graphs and tables should not duplicate each other. Analyses of the data by variables such as age and sex should be included wherever appropriate.

    15. Discussion
    16. The discussion should deal with the interpretation of results but information already presented under Results should not be repeated. New findings should be related to the known ones and with logical deductions. Any weaknesses/limitations/lacunae of the study should be mentioned. The conclusions can be linked with the objectives of the study but conclusions not supported by the data should be strictly avoided. Claiming of priority on work that is ongoing should also be avoided. Recommendations may be included as part of the Discussion, only when clearly supported by data.

      Summary of key findings (primary outcome measures, secondary outcome measures, results as they relate to a prior hypothesis); strengths and limitations of the study (study question, study design, data collection, analysis and interpretation); interpretation and implications in the context of the totality of and future research directions should be included.

    17. Acknowledgment
    18. Acknowledgment should be brief. Specific scientific/technical assistance and financial support only may be acknowledged but providing routine departmental facilities and encouragement or for help in the preparation of the manuscripts (including typing or secretarial assistance)do not merit acknowledgement.

    19. Acknowledgment
    20. Acknowledgment should be brief. Specific scientific/technical assistance and financial support only may be acknowledged but providing routine departmental facilities and encouragement or for help in the preparation of the manuscripts (including typing or secretarial assistance)do not merit acknowledgement.


  7. Review Articles:
  8. These articles should be written by individuals who have done substantial work on the subject or are experts in the field. Articles by other public health experts can be accepted on the basis of merit of article. A short summary of the work done by the contributor(s) in the field of review/their area of expertise should accompany the manuscript.

    The prescribed word count is up to 3000 words excluding tables, references and abstract. The manuscript may have about 90 references. The manuscript should have an unstructured summary (250 words. The section titles would depend upon the topic reviewed. Methods used for locating, selecting, extracting, and synthesizing data should be described. These methods should also be summarized in the abstract. The maximum number of tables and or/figures should be restricted to six.

    Review articles could be authored by upto six authors.

  9. Short communication/Brief Report
  10. Short communication should contain interesting observations/ brief reports of original studies presenting the authors' views on a topic of current interest. The purpose of a short communication / brief reports is to provide additional insights into topics of current public health concerns. Short Communication should be limited to 1,500 words with unstructured summary not exceeding 150 words, no more than two tables and/or figures, and no more than 10 references. Short communication could be authored by up to six authors. Ethical consideration as per original article should be followed.

  11. Case Studies/Case Series:
  12. New, interesting and intriguing case studies can be reported. They should be unique and have demonstrated methods to overcome any public health challenge by use of novel tools and techniques and provide a learning point for the readers. Case studies with public health significance or implications will be given priority. These communications could be of up to 1000 words (excluding Abstract and references) and should have the following headings: Abstract (unstructured summary not exceeding 150 words), Key-words, Introduction, Case report, Discussion, Reference, Tables and Legends in that order.

    The manuscript could be of up to 1000 words (excluding references and abstract) and could be supported with up to 10 references.

    Case Reports could be authored by up to four authors.

  13. Education forum:
  14. Education forum articles should review, discuss and deliberate on recent advances in public health practice and research. The focus should be on methodological issues related to tools and techniques in public health research, operational issues of practice of public health and scaling up of interventions. The manuscript could be of up to 1000 words (excluding references and abstract) and could be supported with up to 10 references. An unstructured summary not exceeding 150 words should be provided.

    Number of authors should be restricted to maximum four.

  15. Letter to the Editor:
  16. These should be short and decisive observations. They should preferably be related to articles previously published in the Journal or views expressed in the journal. They should not be preliminary observations that need a later paper for validation. The letter could have up to 500 words and 5 references. It could be generally authored by not more than four authors.

  17. Others:
  18. Editorial, Guest Editorial (no summary/abstract needed) and sharing of experiences in the field of public health/Commentary (with unstructured summary of about 100-150 words) are solicited by the editorial board.

  19. References:
  20. The total number of References should normally be restricted to a maximum of 30.

    References to literature cited should be numbered consecutively and placed at the end of the manuscript. In the text they should be indicated above the line (superior). Mentioning names of author(s) under references should be avoided in text.

    Articles in Journals: The titles of the journals should be abbreviated according to the style used by the Pub Med.

  1. Standard journal article
  2. List the first six authors followed by et al.

    Halpern SD, Ubel PA, Caplan AL. Solid-organ transplantation in HIV-infected patients. N Engl J Med 2002; 347 : 284-7.

    More than six authors:

    Rose ME, Huerbin MB, Melick J, Marion DW, Palmer AM, Schiding JK, et al. Regulation of interstitial excitatory amino acid concentrations after cortical contusion injury. Brain Res. 2002;935(1-2):40-6.

  3. Organization as author

  4. Diabetes Prevention Program Research Group. Hypertension, insulin, and proinsulin in participants with impaired glucose tolerance. Hypertension. 2002;40(5):679-86.

  5. Both personal authors and an organization as author

  6. Vallancien G, Emberton M, Harving N, van Moorselaar RJ; Alf-One Study Group. Sexual dysfunction in 1,274 European men suffering from lower urinary tract symptoms. J Urol. 2003;169(6):2257-61.

  7. No author given

  8. 21st century heart solution may have a sting in the tail. BMJ. 2002;325(7357):184.

  9. Article not in English


  10. Ellingsen AE, Wilhelmsen I. Sykdomsangst blant medisin- og jusstudenter. Tidsskr Nor Laegeforen. 2002;122(8):785-7.

  11. Volume with supplement
  12. Geraud G, Spierings EL, Keywood C. Tolerability and safety of frovatriptan with short- and long-term use for treatment of migraine and in comparison with sumatriptan. Headache. 2002;42 Suppl 2:S93-9.

  13. Issue with supplement

  14. Glauser TA. Integrating clinical trial data into clinical practice. Neurology. 2002;58(12 Suppl 7):S6-12.

  15. Volume with part

  16. Abend SM, Kulish N. The psychoanalytic method from an epistemological viewpoint. Int J Psychoanal. 2002;83(Pt 2):491-5.

  17. Issue with part

  18. Ahrar K, Madoff DC, Gupta S, Wallace MJ, Price RE, Wright KC. Development of a large animal model for lung tumors. J Vasc Interv Radiol. 2002;13(9 Pt 1):923-8.

  19. . Issue with no volume

  20. Banit DM, Kaufer H, Hartford JM. Intraoperative frozen section analysis in revision total joint arthroplasty. Clin Orthop. 2002;(401):230-8.

  21. No volume or issue

  22. Outreach: bringing HIV-positive individuals into care. HRSA Careaction. 2002 Jun:1-6.

  23. . Pagination in roman numerals

  24. Chadwick R, Schuklenk U. The politics of ethical consensus finding. Bioethics. 2002;16(2):iii-v.

  25. Type of article indicated as needed
  26. Tor M, Turker H. International approaches to the prescription of long-term oxygen therapy [letter]. Eur Respir J. 2002;20(1):242.
    Lofwall MR, Strain EC, Brooner RK, Kindbom KA, Bigelow GE. Characteristics of older methadone maintenance (MM) patients [abstract]. Drug Alcohol Depend. 2002;66 Suppl 1:S105.

  27. Article containing retraction
  28. Feifel D, Moutier CY, Perry W. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone. J Clin Psychiatry. 2002;63(2):169. Retraction of: Feifel D, Moutier CY, Perry W. J Clin Psychiatry. 2000;61(12):909-11.

  29. Article retracted
  30. Feifel D, Moutier CY, Perry W. Safety and tolerability of a rapidly escalating dose-loading regimen for risperidone. J Clin Psychiatry. 2000;61(12):909-11. Retraction in: Feifel D, Moutier CY, Perry W. J Clin Psychiatry. 2002;63(2):169.

  31. Article republished with corrections

  32. Mansharamani M, Chilton BS. The reproductive importance of P-type ATPases. Mol Cell Endocrinol. 2002;188(1-2):22-5. Corrected and republished from: Mol Cell Endocrinol. 2001;183(1-2):123-6.

  33. Article with published erratum

  34. Malinowski JM, Bolesta S. Rosiglitazone in the treatment of type 2 diabetes mellitus: a critical review. Clin Ther. 2000;22(10):1151-68; discussion 1149-50. Erratum in: Clin Ther 2001;23(2):309.

  35. Article published electronically ahead of the print version

  36. Yu WM, Hawley TS, Hawley RG, Qu CK. Immortalization of yolk sac-derived precursor cells. Blood. 2002 Nov 15;100(10):3828-31. Epub 2002 Jul 5.

    Books and Other Monographs

  37. Personal author(s)

  38. Murray PR, Rosenthal KS, Kobayashi GS, Pfaller MA. Medical microbiology. 4th ed. St. Louis: Mosby; 2002.

  39. Editor(s), compiler(s) as author

  40. Gilstrap LC 3rd, Cunningham FG, VanDorsten JP, editors. Operative obstetrics. 2nd ed. New York: McGraw-Hill; 2002.

  41. Author(s) and editor(s)

  42. Breedlove GK, Schorfheide AM. Adolescent pregnancy. 2nd ed. Wieczorek RR, editor. White Plains (NY): March of Dimes Education Services; 2001.

  43. Organization(s) as author
  44. Royal Adelaide Hospital; University of Adelaide, Department of Clinical Nursing. Compendium of nursing research and practice development, 1999-2000. Adelaide (Australia): Adelaide University; 2001.

  45. Chapter in a book
  46. Meltzer PS, Kallioniemi A, Trent JM. Chromosome alterations in human solid tumors. In: Vogelstein B, Kinzler KW, editors. The genetic basis of human cancer. New York: McGraw-Hill; 2002. p. 93-113.

  47. Conference proceedings

  48. Harnden P, Joffe JK, Jones WG, editors. Germ cell tumours V. Proceedings of the 5th Germ Cell Tumour Conference; 2001 Sep 13-15; Leeds, UK. New York: Springer; 2002.

  49. Conference paper
  50. Christensen S, Oppacher F. An analysis of Koza's computational effort statistic for genetic programming. In: Foster JA, Lutton E, Miller J, Ryan C, Tettamanzi AG, editors. Genetic programming. EuroGP 2002: Proceedings of the 5th European Conference on Genetic Programming; 2002 Apr 3-5; Kinsdale, Ireland. Berlin: Springer; 2002. p. 182-91.

  51. Scientific or technical report
  52. Issued by funding/sponsoring agency:

    Yen GG (Oklahoma State University, School of Electrical and Computer Engineering, Stillwater, OK). Health monitoring on vibration signatures. Final report. Arlington (VA): Air Force Office of Scientific Research (US), Air Force Research Laboratory; 2002 Feb. Report No.: AFRLSRBLTR020123. Contract No.: F496209810049.

    Issued by performing agency:

    Russell ML, Goth-Goldstein R, Apte MG, Fisk WJ. Method for measuring the size distribution of airborne Rhinovirus. Berkeley (CA): Lawrence Berkeley National Laboratory, Environmental Energy Technologies Division; 2002 Jan. Report No.: LBNL49574. Contract No.: DEAC0376SF00098. Sponsored by the Department of Energy.

  53. Dissertation

  54. Borkowski MM. Infant sleep and feeding: a telephone survey of Hispanic Americans [dissertation]. Mount Pleasant (MI): Central Michigan University; 2002.

  55. Patent
  56. Pagedas AC, inventor; Ancel Surgical R&D Inc., assignee. Flexible endoscopic grasping and cutting device and positioning tool assembly. United States patent US 20020103498. 2002 Aug 1.

    Other Published Material

  57. Newspaper article

  58. Tynan T. Medical improvements lower homicide rate: study sees drop in assault rate. The Washington Post. 2002 Aug 12;Sect. A:2 (col. 4).

  59. Audiovisual material

  60. Chason KW, Sallustio S. Hospital preparedness for bioterrorism [videocassette]. Secaucus (NJ): Network for Continuing Medical Education; 2002.

  61. Legal Material
  62. Public law:
    Veterans Hearing Loss Compensation Act of 2002, Pub. L. No. 107-9, 115 Stat. 11 (May 24, 2001).

    Unenacted bill:
    Healthy Children Learn Act, S. 1012, 107th Cong., 1st Sess. (2001).

    Code of Federal Regulations:
    Cardiopulmonary Bypass Intracardiac Suction Control, 21 C.F.R. Sect. 870.4430 (2002).

    Hearing:
    Arsenic in Drinking Water: An Update on the Science, Benefits and Cost: Hearing Before the Subcomm. on Environment, Technology and Standards of the House Comm. on Science, 107th Cong., 1st Sess. (Oct. 4, 2001).

  63. Map

  64. Pratt B, Flick P, Vynne C, cartographers. Biodiversity hotspots [map]. Washington: Conservation International; 2000.

  65. Dictionary and similar references

  66. Dorland's illustrated medical dictionary. 29th ed. Philadelphia: W.B. Saunders; 2000. Filamin; p. 675.

    Unpublished Material

  67. In press

  68. (Note: NLM prefers "forthcoming" because not all items will be printed.)

    Tian D, Araki H, Stahl E, Bergelson J, Kreitman M. Signature of balancing selection in Arabidopsis. Proc Natl Acad Sci U S A. In press 2002.

    Electronic Material

  69. CD-ROM

  70. Anderson SC, Poulsen KB. Anderson's electronic atlas of hematology [CD-ROM]. Philadelphia: Lippincott Williams & Wilkins; 2002.

  71. Journal article on the Internet
  72. Abood S. Quality improvement initiative in nursing homes: the ANA acts in an advisory role. Am J Nurs [serial on the Internet]. 2002 Jun [cited 2002 Aug 12];102(6):[about 3 p.]. Available from: http://www.nursingworld.org/AJN/2002/june/Wawatch.htm

  73. Monograph on the Internet

  74. Foley KM, Gelband H, editors. Improving palliative care for cancer [monograph on the Internet]. Washington: National Academy Press; 2001 [cited 2002 Jul 9]. Available from: http://www.nap.edu/books/0309074029/html/.

  75. Homepage/Web site

  76. Cancer-Pain.org [homepage on the Internet]. New York: Association of Cancer Online Resources, Inc.; c2000-01 [updated 2002 May 16; cited 2002 Jul 9]. Available from: http://www.cancer-pain.org/.

  77. Part of a homepage/Web site

  78. American Medical Association [homepage on the Internet]. Chicago: The Association; c1995-2002 [updated 2001 Aug 23; cited 2002 Aug 12]. AMA Office of Group Practice Liaison; [about 2 screens]. Available from: http://www.ama-assn.org/ama/pub/category/1736.html

  79. Database on the Internet
  80. Open database:
    Who's Certified [database on the Internet]. Evanston (IL): The American Board of Medical Specialists. c2000 - [cited 2001 Mar 8]. Available from:http://www.abms.org/newsearch.asp

    Closed database:
    Jablonski S. Online Multiple Congential Anomaly/Mental Retardation (MCA/MR) Syndromes [database on the Internet]. Bethesda (MD): National Library of Medicine (US). c1999 [updated 2001 Nov 20; cited 2002 Aug 12]. Available from: http://www.nlm.nih.gov/mesh/jablonski/syndrome_title.html

  81. Part of a database on the Internet
  82. MeSH Browser [database on the Internet]. Bethesda (MD): National Library of Medicine (US); 2002 - [cited 2003 Jun 10]. Meta-analysis; unique ID: D015201; [about 3 p.]. Available from: http://www.nlm.nih.gov/mesh/MBrowser.html Files updated weekly.

    MeSH Browser [database on the Internet]. Bethesda (MD): National Library of Medicine (US); 2002 - [cited 2003 Jun 10]. Meta-analysis; unique ID: D015201; [about 3 p.]. Available from: http://www.nlm.nih.gov/mesh/MBrowser.html Files updated weekly.

    Tables

    Tables should be typed separately and numbered consecutively with Roman numerals (I, II, III, etc). They should bear brief title and column headings should also be short. Units of measurement should be abbreviated and placed below the headings. Statistical measurement variations such as SD and SE should be identified. Inclusion of structural formulae in Tables should be avoided. Also, Tables should not be submitted as photographs.

    Illustrations

    Illustrations should be submitted in JPEG or TIFF format (size not more than 1 MB), numbered consecutively in Arabic numerals with appropriate Title and explanation of symbols in the legends for illustrations.

    Photomicrographs should have internal scale markers regarding details of magnification to facilitate reduction in size in final print. Symbols, arrows and letters used in the photomicrographs should contrast with the background.

    All published material should be acknowledged and copyright material should be submitted along with the written permission of the copyright holder.

    Abbreviations

    Only standard abbreviations are to be used. The abbreviations should conform to the International System of Units (SI), throughout the text, Tables and Figures. Generic names of the drugs should be used. If proprietary brands are used in research brand name, name of manufacturer and country should be given in parentheses after the generic name at the first place of use.

    Sending a revised manuscript

    The revised version of the manuscript should be submitted in a manner similar to that used for submission of the manuscript for the first time. When submitting a revised manuscript, contributors are requested to include, the 'referees' remarks along with point to point clarification at the beginning in the revised file itself. In addition, they are expected to mark the changes as underlined or colored text in the article.

    AUTHORS’ CONTRIBUTIONS

    All authors are encouraged to specify their individual contributions at the bottom of the title page or on a separate page. The IJHPH will not publish an item unless it has the signatures of all the authors. Participation solely in the acquisition of funding or the collection of data does not justify authorship. General supervision of the research group is also not sufficient for authorship. Any part of an article critical to its main conclusions must be the responsibility of at least one author.

    LICTS OF INTEREST

    A conflict of interest exists if authors or their institutions have financial or personal relationships with other people or organizations that could inappropriately influence (bias) their actions. A conflict can be actual or potential, and full disclosure to the Editor is absolute requirement. All submissions must include disclosure of all relationships that could be viewed as presenting a potential conflict of interest.

    All authors must disclose any financial and personal relationships with other people or organizations that could inappropriately influence (bias) their work. If there are no conflicts of interest, authors should state so.

    UNDERTAKING BY AUTHOR(S)

    All authors need to give an undertaking (in the format specified by the journal) indicating their consent to be co-authors in the sequence indicated on the title page. Each author should give his or her names as well as the address and appointment current at the time the work was done, plus a current address for correspondence including telephone and fax numbers and email address. A senior author may sign the Undertaking by Authors for a junior author who has left the institution and whose whereabouts are not known and take the responsibility.

    A paper with corporate (collective) authorship must specify the key persons responsible for the article; others contributing to the work should be recognized separately.

    COPYRIGHT TRANSFER AGREEMENT

    Author(s) will be asked to sign a transfer of copyright agreement, which recognizes the common interest that both journal and author(s) have in the protection of copyright

    Undertaking by Authors

    This document must be signed by all authors and a scanned copy of the same should be submitted with the manuscript.

    We, the undersigned, give an undertaking to the following effect with regard to our article entitled ".....” submitted for publication in the Indian Journal of Hygiene & Public Health:

    1. The article mentioned above has not been published or submitted to or accepted for publication in any form, in any other journal.

    2. We also vouchsafe that the authorship of this article will not be contested by anyone whose name(s) is/are not listed by us here.

    3. I/We declare that I/We contributed significantly towards the research study i.e., (a) conception, design and/or analysis and interpretation of data and to (b) drafting the article or revising it critically for important intellectual content and on (c) final approval of the version to be published.

    4. I/We hereby acknowledge IJHPH’s conflict of interest policy requirement to scrupulously avoid direct and indirect conflicts of interest and, accordingly, hereby agree to promptly inform the editor or editor's designee of any business, commercial, or other proprietary support, relationships, or interests that I/We may have which relate directly or indirectly to the subject of the work.


    5. I/We also agree to the authorship of the article in the following sequence:-

    Authors' Names (in sequence) Signature of Authors
    1 -------------------------------------- --------------------------------------
    2 -------------------------------------- --------------------------------------
    3 -------------------------------------- --------------------------------------
    4 -------------------------------------- --------------------------------------
    5 -------------------------------------- --------------------------------------
    6 -------------------------------------- --------------------------------------
    7 -------------------------------------- --------------------------------------
    8 -------------------------------------- --------------------------------------

    Important

    (i). All the authors are required to sign independently in this form in the sequence given above. In case an author has left the institution/country and whose whereabouts are not known, the senior author may sign on his/her behalf taking the responsibility.

    (ii). No addition/deletion/ or any change in the sequence of the authorship will be permissible at a later stage, without valid reasons and permission of the Editor.

    (iii). If the authorship is contested at any stage, the article will be either returned or will not be processed for publication till the issue is solved.

    Copyright Transfer Agreement Form

    This document must be signed by all authors and a scanned copy of the same should be submitted with the manuscript.

    COPYRIGHT TRANSFER AGREEMENT


    The Indian Journal of Hygiene and Public Health (IJHPH) is a publication of All India Institute of Hygiene & Public Health, Kolkata. The Indian Journal of Hygiene and Public Health and Authors hereby agree as follows: In consideration of IJHPH reviewing and editing the following described work for first publication on an exclusive basis:

    Title of manuscript: ----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

    The undersigned author(s) hereby assigns, conveys, and otherwise transfers all rights, title, interest, and copyright ownership of said work for publication. Work includes the material submitted for publication and any other related material submitted to Indian Journal of Hygiene and Public Health. In the event that Indian Journal of Hygiene and Public Health does not publish said work, the author(s) will be so notified and all rights assigned hereunder will revert to the author(s).

    The assignment of rights to IJHPH includes but is not expressly limited to rights to edit, publish, reproduce, distribute copies, include in indexes or search databases in print, electronic, or other media, whether or not in use at the time of execution of this agreement, and claim copyright in said work throughout the world for the full duration of the copyright and any renewals or extensions thereof.

    All accepted works become the property of IJHPH and may not be published elsewhere without prior written permission from IJHPH. The author(s) hereby represents and warrants that they are sole author(s) of the work, that all authors have participated in and agree with the content and conclusions of the work, that the work is original, and does not infringe upon any copyright, propriety, or personal right of any third party, and that no part of it nor any work based on substantially similar data has been submitted to another publication.

    Authors' Names (in sequence) Signature of Authors
    1 -------------------------------------- --------------------------------------
    2 -------------------------------------- --------------------------------------
    3 -------------------------------------- --------------------------------------
    4 -------------------------------------- --------------------------------------
    5 -------------------------------------- --------------------------------------
    6 -------------------------------------- --------------------------------------
    7 -------------------------------------- --------------------------------------
    8 -------------------------------------- --------------------------------------